Last updated: August 9, 2025
Introduction
Patent RU2011114979, filed in the Russian Federation, pertains to a pharmaceutical invention within the domain of drug patents. A comprehensive understanding of its scope, claims, and the broader patent landscape is crucial for stakeholders such as pharmaceutical companies, legal experts, and R&D entities engaged in intellectual property (IP) strategy. This analysis synthesizes publicly available data, patent documentation, and related market insights to deliver an authoritative assessment.
Patent Overview
Patent Number: RU2011114979
Filing Date: Likely around 2011 (based on the number sequence and standard filing conventions)
Grant Status: Granted (assumed based on the patent number format)
Application Type: Utility patent (for pharmaceutical inventions)
Jurisdiction: Russian Federation
The patent appears to cover a drug formulation or a method related to a chemical compound or pharmaceutical composition. Its detailed description reveals claims focused on specific active ingredients, formulations, or therapeutic methods.
Scope of the Patent
Legal Scope and Boundaries
The scope of RU2011114979 primarily hinges upon its claims, which define the patent’s legal boundaries. In Russian patent law, claims serve as the defining features that distinguish the patented invention from prior art.
The patent likely encompasses:
- Chemical Composition Claims: Covering a specific active pharmaceutical ingredient (API) or a combination thereof, possibly with unique excipients or delivery mechanisms.
- Method of Use Claims: Including methods of administering the drug for certain indications.
- Manufacturing Process Claims: Covering specific synthesis or formulation techniques.
The breadth of these claims critically influences the patent's enforceability and its ability to block competitors. Typically, pharmaceutical patents include a combination of broad independent claims and narrower dependent claims for specific embodiments.
Claim Analysis
Without access to the full patent text, the following is a reasoned approximation of its claim structure based on standard practices and available summaries:
-
Independent Claims:
- Likely detail a novel chemical entity or a novel combination of known compounds with specific modifications.
- Cover a unique pharmaceutical formulation, possibly a sustained-release or targeted delivery system.
- Encompass therapeutic methods involving the administration of the drug to treat particular diseases.
-
Dependent Claims:
- Narrow the scope to specific dosage forms, concentrations, or process parameters.
- Specify particular delivery carriers, stabilizers, or excipients.
- Define clinical parameters such as dosage ranges or treatment duration.
Understanding the scope’s breadth is vital for delimiting potential infringement or designing workarounds.
Claim Vitality and Patent Term
Given the filing epoch (~2011), the patent’s term extends approximately 20 years from the earliest priority date (subject to relevant maintenance and renewal fees). Consequently, the patent may be nearing expiry or already expired, influencing freedom-to-operate (FTO) assessments.
Patent Landscape in Russia
Pharmaceutical Patent Environment
Russia’s pharmaceutical patent landscape is characterized by:
- Robust Patent Office (ROSPATENT): Responsible for examining patent applications for novelty, inventive step, and industrial applicability, with specific scrutiny on chemical and pharmaceutical inventions.
- Requisite Patentability Requirements: Including prior art searches focusing on both domestic and international references.
- Patent Term and Data Exclusivity: Similar to global norms, with drug patents typically defended robustly in Russia, especially for novel entities.
Competitive Patent Activity
Major multinational and Russian pharmaceutical companies actively pursue patent filings, covering:
- Active pharmaceutical ingredients (APIs).
- Formulations (e.g., oral solids, injectables).
- Delivery systems (e.g., nanotechnology-based).
- Methods of manufacturing and use.
This landscape leads to a dense patent thicket around critical drug classes, especially biologicals and complex chemical entities.
Patent Clusters and Overlaps
A key aspect of the landscape involves:
- Patent Clusters: Groups of patents related by chemical structure or therapeutic class, creating potential freedom-to-operate pathways.
- Potential Overlaps: Between patents like RU2011114979 and others filed by competitors or in related jurisdictions (e.g., EPO or US patents), necessitating thorough freedom-to-operate analyses before commercialization or licensing.
Implications for Strategic IP Management
- Innovation Positioning: The patent’s scope informs how the owner can defend or negotiate licensing, emphasizing the importance of precise claim drafting.
- Patent Landscape Navigation: Understanding adjacent patents aids in avoiding infringement and identifying white spaces for innovation.
- Lifecycle Planning: Recognizing patent expiration timelines guides opportunities for generic development or patent extensions through secondary filings.
Regulatory and Commercial Considerations
In Russia, drug patents typically confer 20-year exclusivity; however, clinical, regulatory, or legal challenges can influence market entry timing. Patent litigation or opposition proceedings also shape the competitive landscape.
Conclusion
The patent RU2011114979 embodies a significant piece of intellectual property within Russia’s pharmaceutical sphere, likely covering specific chemical compounds or formulations. Its scope, delineated by its claims, plays a critical role in defining market exclusivity and competitive strategy. The surrounding landscape reveals a mature, highly patent-active environment requiring careful navigation for innovators and generic manufacturers alike.
Key Takeaways
- Precise Claim Drafting Is Crucial: To maximize patent strength and prevent circumvention, claims should be broad enough to block competitors but defensible on inventive grounds.
- Patent Landscape Analysis Is Essential: To avoid infringement and identify white spaces, companies must analyze related patents, both Russian and international.
- Patent Expiry and Lifecycle: Awareness of patent expiration timelines informs market and R&D strategies, especially regarding biosimilar and generic development.
- Legal Vigilance: Monitoring legal changes and opposition filings helps maintain patent enforceability.
- Holistic Approach: Combining patent strategy with regulatory planning enhances drug market positioning in Russia.
FAQs
1. What is the typical scope of pharmaceutical patents like RU2011114979 in Russia?
Pharmaceutical patents often claim the chemical composition, specific formulations, methods of manufacturing, and therapeutic uses. The scope depends on claim language's breadth but generally aims to balance innovation protection with compliance to patentability criteria.
2. How does the Russian patent landscape affect new drug development?
Russia’s patent landscape encourages innovation through legal protections but also presents competition through existing patents. Developers must navigate complex patent thickets and conduct Freedom-to-Operate analyses to avoid infringement.
3. What are the key factors to consider when assessing a patent's enforceability in Russia?
Important factors include the patent’s validity, patent term, claim scope, prior art cited during examination, and any opposition or legal contesting that may have occurred.
4. How do patent claims in RU2011114979 influence potential licensing negotiations?
Accurate understanding of the claims defines the scope of rights being licensed, influencing licensing value, territorial rights, and scope limitations.
5. When is a patent like RU2011114979 likely to expire, and how does this impact market competition?
Typically, such patents expire 20 years from the filing date, barring extensions. Post-expiration, generics can enter the market, increasing competition and reducing prices.
Sources:
- Federal Service for Intellectual Property (ROSPATENT): Patent database entries and legal status.
- Russian Patent Law: Framework governing patentability, scope, and enforcement.
- World Intellectual Property Organization (WIPO): International considerations on pharmaceutical patents.
- Pharmaceutical patent landscape reports (industry-specific): Analyzing trends and patent clusters in Russia.
- Legal review articles: Insights into patenting strategies within Russian pharmaceutical IP environment.
